中医药传承创新行动合作项目启动

2018-07-10 葛伟韬 中国中医

中医药传承创新行动合作项目启动会暨公立中医院绩效改革与发展论坛在京举办。

中医药传承创新行动合作项目启动会暨公立中医院绩效改革与发展论坛在京举办。

国家中医药管理局副局长马建中表示,深化医药卫生体制改革是党中央、国务院为改善民生和提高人民健康水平做出的重大决策。中医医院作为中医药事业发展的主阵地,在发挥中医药特色优势、推动中医临床科研相结合、突显中医药贡献率、维护和增进人民群众健康等方面具有不可替代的重要作用。

中医药传承创新行动由中国中医药科技开发交流中心发起并组织实施,旨在紧扣公立中医院管理的关键环节,整合资源、发挥优势,组织协调行业内外多学科、多领域、多层次的力量,助力医院不断提高核心竞争力,更好地发挥中医药特色优势和服务广大人民群众健康。

会上,中国中医药科技开发交流中心和中国中医科学院西苑医院合作共建的“医院中药饮片质量及临床服务管理示范中心”“中医、中西医结合专科绩效考核管理研究与协作中心”“中医临床研究基地建设关键技术研究与交流中心”等项目启动。

中国中医药科技开发交流中心和中国中医科学院西苑医院合作共建的“医院中药饮片质量及临床服务管理示范中心”“中医等项目启动。

论坛由西苑医院、中国中医药科技开发交流中心主办。国家中医药管理局医政司司长蒋健、中国中医科学院党委书记王炼及100余位中医药专家参会。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675589, encodeId=736316e55894d, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Nov 02 01:50:00 CST 2018, time=2018-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796821, encodeId=f2cd1e968218c, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 27 17:50:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285609, encodeId=97971285609fb, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409624, encodeId=69b914096248a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
    2018-11-02 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675589, encodeId=736316e55894d, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Nov 02 01:50:00 CST 2018, time=2018-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796821, encodeId=f2cd1e968218c, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 27 17:50:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285609, encodeId=97971285609fb, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409624, encodeId=69b914096248a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675589, encodeId=736316e55894d, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Nov 02 01:50:00 CST 2018, time=2018-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796821, encodeId=f2cd1e968218c, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 27 17:50:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285609, encodeId=97971285609fb, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409624, encodeId=69b914096248a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1675589, encodeId=736316e55894d, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Fri Nov 02 01:50:00 CST 2018, time=2018-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796821, encodeId=f2cd1e968218c, content=<a href='/topic/show?id=969121500e5' target=_blank style='color:#2F92EE;'>#中医药传承创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21500, encryptionId=969121500e5, topicName=中医药传承创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e7948, createdName=李研东, createdTime=Fri Jul 27 17:50:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285609, encodeId=97971285609fb, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409624, encodeId=69b914096248a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jul 12 04:50:00 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
    2018-07-12 cathymary

相关资讯

中医药现代化、生殖健康等12个国家重点研发计划重点专项2018年申报指南

各省、自治区、直辖市及计划单列市科技厅(委、局),新疆生产建设兵团科技局,国务院各有关部门科技主管司局,各有关单位:

余艳红看望优秀共产党员屠呦呦

“今天是党的生日,您是共产党员的杰出代表,我代表国家中医药管理局党组向您,并通过您向中医药系统的老专家、老党员表示衷心感谢并致以崇高敬意!”

新华社:让中医药服务离百姓更近!中医药法实施一周年热点透视

引人关注的《中华人民共和国中医药法》自去年7月1日实施至今已满一年。一年来,法治体系“踩足油门”加速构建,不断“激活”中医药服务供给能力,给老百姓带来诸多实惠,为护佑人类健康做出新的贡献。

山东省政府发布健康产业规划:建设6个中医药省级工程技术中心

山东省政府印发《山东省医养健康产业发展规划(2018-2022年)》。这是全国首个由省级卫生计生委牵头制定的健康产业规划,其中将中医药作为重点领域进行专题部署,提出建设6个中医药省级工程技术中心,培育60家规模以上中医药龙头企业。

中国行活动国博现场报道:中医药增强百姓获得感幸福感

中医中药中国行——2018年中医药健康文化大型主题活动6月30日在中国国家博物馆开幕,专家义诊、展览展示、文化体验、健康讲座等活动同期举行。

国家中医药管理局党组召开会议

国家中医药管理局党组召开会议,传达学习习近平总书记在全国组织工作会议和中央政治局第六次集体学习上的重要讲话精神,系统学习习近平总书记关于中医药工作的系列重要指示精神,研究贯彻落实措施。国家卫生健康委党组成员、国家中医药管理局党组书记余艳红主持会议。党组成员马建中、王志勇、闫树江出席会议,局长于文明列席会议。